Skip to content

Clinical trials

Phase 3 Movement Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Movement Disorders Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20132
20142
20192
20202
20211
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Auspex Pharmaceuticals, Inc.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire, Amiens1
Emalex Biosciences Inc.1
Neurocrine Biosciences1
Ono Pharmaceutical Co., Ltd.1
Praxis Precision Medicines1
Universidad de Murcia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Movement Disorders16
Central Nervous System Diseases10
Brain Diseases8
Nervous System Diseases8
Neurodegenerative Diseases6
Parkinson Disease6
Parkinsonian Disorders6
Basal Ganglia Diseases3
Mental Disorders3
Tardive Dyskinesia3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.